Tranexamic Acid USP For Compounding (API)

Topiramate USP for Compounding (API) is an active pharmaceutical ingredient used to create personalized medications for managing epilepsy and migraine prophylaxis. Known for its anticonvulsant properties, it helps control seizures and reduce the frequency of migraines by stabilizing electrical activity in the brain. In a compounding setting, pharmacists can tailor specific dosages and formulations to meet unique patient needs, especially for those who experience adverse effects with standard treatments or require customized dosage forms for effective management.

Tranexamic Acid USP for compounding is a medication used for the treatment or prevention of excessive bleeding or hemorrhage. It is commonly used during surgeries, dental procedures, and for heavy menstrual bleeding. Tranexamic Acid works by preventing the breakdown of blood clots, thereby reducing bleeding. It is also used as an antifibrinolytic agent to treat conditions such as hemophilia and von Willebrand disease. This medication is only available for compounding, which means it is not a commercially available product and must be prepared by a licensed pharmacist according to a specific formula prescribed by a healthcare provider. 

Tranexamic acid USP is an active pharmaceutical ingredient (API) used in prescription medications. It belongs to the class of drugs called antifibrinolytics, which work by preventing the breakdown of blood clots in the body.

Tranexamic acid USP is primarily used to prevent or treat excessive bleeding in patients with certain medical conditions, such as bleeding disorders, heavy menstrual bleeding, and postpartum hemorrhage. It is also used in dentistry and in surgeries to reduce bleeding.

Tranexamic acid USP is a synthetic form of the amino acid lysine and is available in various forms such as tablets, injections, and nasal sprays. It works by blocking the activity of plasmin, an enzyme responsible for breaking down blood clots. This helps to maintain normal blood clotting and control bleeding.

As an API, tranexamic acid USP is subject to strict quality control measures and must meet specific criteria for purity, strength, potency, and stability set by the USP. It is approved by the US Food and Drug Administration (FDA) and is considered safe and effective when used as directed by a healthcare professional.

CAS Number: 1197-18-8